MBX Biosciences Inc. Common Stock

MBX | NASDAQ

Price Alert Chart Builder DCF Calculator

$60.94

-$1.97 (-3.13%)

At close: Sep 21, 2026, 4:00 PM ET

$60.94

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.99B

Enterprise Value $2.49B

Beta 0.10

Average Volume 718.28K

Shares Outstanding (Diluted) 47.7M

Shares Change YoY 42.61%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US55287L1017

Price Performance

Price Change 1M -7.1%

Price Change 3M 31.4%

Price Change 6M 110.4%

Price Change YTD 99.5%

Price Change 1Y 204.7%

Price Change 3Y 157.7%

Price Change 5Y 157.7%

1M CAGR (ann.) -6.3%

1Y CAGR (ann.) 532.9%

5Y CAGR (ann.) N/A

All-Time CAGR 62.5%

Valuation

PE Ratio -25.39

Forward PE N/A

PEG Ratio 4.50

Forward PEG -0.88

PS Ratio N/A

Forward PS N/A

PB Ratio 7.08

P/FCF Ratio -27.40

P/Adj. FCF Ratio -22.70

P/OCF Ratio -35.23

EV/Sales N/A

EV/EBIT -36.99

EV/EBITDA -23.02

EV/FCF -23.48

Earnings Yield -3.9%

FCF Yield -3.6%

Adj. FCF Yield -4.4%

Financial Health

Net Cash $415.24M

Total Debt $3.34M

Cash & Short-Term Investments $418.58M

Total Assets $435.91M

Current Ratio 18.08

Quick Ratio 18.08

Debt / Equity Ratio 0.01

Debt / EBITDA -0.03

Debt / FCF -0.03

OCF / Debt -30.79

Interest Coverage 0.00

Altman Z-Score 67.82

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -20.7%

Returns

Return on Assets -23.9%

Return on Equity -26.0%

Return on Invested Capital -28.6%

Return on Capital Employed -28.6%

Return on Tangible Assets -23.9%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -23.2%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -42.2%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 7

EPS Growth Next 3Y -2.4%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.84

EPS Growth Est (next Q) 33.1%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $80.50

Price Target Upside 32.1%

Cash Flow

Operating Cash Flow $-102.88M

Free Cash Flow $-105.84M

Adj. Free Cash Flow $-127.78M

FCF Per Share -$1.79

OCF Per Share -$1.73

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-224K

Operating Income $-117.92M

EBITDA $-107.95M

Net Income $-104.29M

EPS (Diluted) -$2.40

Revenue / Employee N/A

Profit / Employee $-1.66M

Employees 63